Rare diseases
Investigational molecules
Locations
Back to Italy1 clinical trial in Lanciano, Italy. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in ItalyStudi-Clinici.it(opens in a new tab)ItalyThe busiest research cities in the country
What the registry says about research in the country
Investigating optimal treatment timing for early breast cancer patients, specifically focusing on the administration of chemotherapy and aromatase inhibitors in post-menopausal women.
This research addresses a critical question in breast cancer treatment, examining whether concurrent or sequential administration of therapies provides better outcomes for patients with endocrine-responsive tumors.
Advancing understanding of treatment protocols for the most common cancer affecting women in North America, Europe, and Latin America.
This research aims to enhance treatment outcomes for the approximately 80% of breast cancer patients whose tumors are endocrine-responsive.
Examining the effectiveness of different approaches to combining endocrine therapy and chemotherapy in early-stage breast cancer treatment.
The research focuses on determining the most effective timing and integration of multiple treatment modalities to improve patient outcomes.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
